Sectors
CLYM
Climb Bio, Inc.
12.76
1 x 12.69
1 x 12.74
bid
ask
-
0.34
2.60%
10:35 AM
timesize
| Ytd | 219.00% | |
| 1y | 804.96% |
12.69
day range
13.22
1.36
52 week range
14.41
| Open | 12.85 | Prev Close | 13.10 | Low | 12.69 | High | 13.22 | Mkt Cap | 893.22M |
| Vol | 66.54K | Avg Vol | 1.26M | EPS | -0.78 | P/E | -16.79 | Forward P/E | N/A |
| Beta | 0.07 | Short Ratio | 15.74 | Inst. Own | 84.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 11.89 | 200-d Avg | 6.65 | 1yr Est | 10.00 |
| Income Statement | |||
| Operating Expenses | 15.21M | ||
| Research and Development Expense | 9.37M | ||
| Selling, General and Administrative Expense | 5.84M | ||
| Operating Income | -15.21M | ||
| Net Income | -13.72M | ||
| Net Income Common Stock | -13.72M | ||
| Net Income Common Stock (USD) | -13.72M | ||
| Consolidated Income | -13.72M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -13.72M | ||
| Earning Before Interest & Taxes (USD) | -13.72M | ||
| Weighted Average Shares | 68.21M | ||
| Weighted Average Shares Diluted | 68.21M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.36M | ||
| Cash and Equivalents (USD) | 8.36M | ||
| Investments | 137.95M | ||
| Investments Current | 101.21M | ||
| Investments Non-Current | 36.74M | ||
| Current Assets | 113.40M | ||
| Property, Plant & Equipment Net | 697.00K | ||
| Total Assets | 152.37M | ||
| Debt Current | 263.00K | ||
| Total Debt | 479.00K | ||
| Current Liabilities | 4.07M | ||
| Debt Non-Current | 216.00K | ||
| Total Liabilities | 4.29M | ||
| Accumulated Retained Earnings (Deficit) | -303.45M | ||
| Accumulated Other Comprehensive Income | 157.00K | ||
| Shareholders Equity | 148.09M | ||
| Shareholders Equity (USD) | 148.09M | ||
| Assets Non-Current | 38.97M | ||
| Total Debt (USD) | 479.00K | ||
| Liabilities Non-Current | 216.00K | ||
| Trade and Non-Trade Payables | 860.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 96.00K | ||
| Net Cash Flow from Financing | 5.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -27.33M | ||
| Issuance (Purchase) of Equity Shares | 5.00K | ||
| Net Cash Flow from Investing | -12.95M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -12.95M | ||
| Net Cash Flow from Operations | -14.38M | ||
| Share Based Compensation | 1.61M | ||